Roche

Roche to Spend $880 Million on Manufacturing, Create 500 Jobs

Germany's Merck Sees Long-Term Growth in Cancer Drug Erbitux

Roche Breast Cancer Drug Gets U.S. Pre-Surgery Approval

Astrazeneca CEO Gets Two Cheers after First Year in Job

Roche Decides Against Selling Diabetes Device Unit

GSK Cancer Drug Combination Wins US Priority Review

Eli Lilly Defends Blockbuster Alimta With Unusual Ammo

India Revokes GSK Cancer Drug Patent In Latest Big Pharma Blow

Siemens, BASF Profit Warnings Hurt European Shares

GSK Says Executives Appear To Have Broken Chinese law

Roche Takes Its Hunt For A New Chairman Further Afield

China Blocks GSK Finance Head From Leaving Country

Novartis Lifts Full-Year Outlook After Competition Delay

Alexion Valuation Could Choke Any Roche Bid

Roche Suffers Diabetes Drug Setback

GlaxoSmithKline to Use Immunocore Drug Technology

European Medicines Agency Pave Way for Biosimilar Drug Breakthrough

After Tech Success, Israel Seeks Life Sciences Growth

Chemical Industry in Transition

Novartis' Vasella Exit Opens Door to Roche Stake Sale

Drugmakers Face More Scrutiny of Discordant U.S. Prices

U.S. Lawmakers Advance Bill on Prescription Drug Tracking

Fast Climbing Biotech Regeneron Still Has Room to Grow

Big Drugmakers Think Small with Nanomedicine Deals

Thermo Fisher takes over Life Technologies for $13.6 Billion

Roche Says No Plans to Change Holding in Japan's Chugai

Tamiflu And Cancer Drugs Lift Roche Above Forecasts

Thermo Bids for Life Tech

Roche to Release All Tamiflu Drug Data

Novartis Loses Landmark India Cancer Drug Patent Case

Big Pharma in Nervous Wait for India Verdict on Glivec Patent

Roche Stays a Step Ahead of Copycat Drugmakers

Antibiotics Crisis Prompts Rethink on Risks, Rewards

Health Firms Demand Bills Overhaul from Spain to Stem Debt

Long-serving Roche Chairman to Step Down Next Year

73 more articles

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Aenova Holding GmbH

Mastering Modified Release: The Pellet-Based Approach

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Novartis Vaccines and Diagnostics GmbH & Co.KG

Thomson Reuters

Arthur D. Little

Bayer AG - Pharmaceuticals Communications & Health Policy

F. Hoffmann-La Roche Ltd

CHEManager International c/o Wiley-VCH GmbH

Scienceindustries - Wirtschaftsverband Chemie Pharma Life Sciences

Datamonitor Group

Lilly Deutschland GmbH

Dishman Europe Ltd.

LISA Life Science Austria

Roche Group

Styron Europe GmbH

GlaxoSmithKline (GSK) plc

Novartis International AG

SchüllerConsulting